, Volume 30, Issue 5, pp 333–343 | Cite as

Aberrant expression of Class II major histocompatibility complex molecules by B cells and hyperexpression of Class I major histocompatibility complex molecules by insulin containing islets in Type 1 (insulin-dependent) diabetes mellitus

  • A. K. Foulis
  • M. A. Farquharson
  • R. Hardman


Twenty-three patients with recent onset Type 1 (insulin-dependent) diabetes in whom residual insulin secreting B cells were present and 12 patients with disease of more prolonged duration (maximum 9 years), 8 of whom had residual B cells, were studied. Aberrant expression of Class II major histocompatibility complex molecules was demonstrated immunohistochemically on insulin secreting B cells in 21 out of 23 patients with recent onset disease and 6 of the patients with more prolonged disease. No such expression was seen on glucagon secreting A cells or somatostatin secreting D cells. Islets where there was marked hyperexpression of Class I major histocompatibility complex molecules on islet endocrine cells were seen in all cases in which residual B cells were present. Ninety-two per cent of insulin containing islets but only 1% of insulin deficient islets exhibited this phenomenon (p<0.001, Chi-squared test). There was evidence to suggest that both these abnormalities of major histocompatibility complex expression preceded insulitis within a given islet. They also appeared to be unique to Type 1 diabetes, being absent in pancreases of patients with Type 2 (non-insulin-dependent) diabetes, chronic pancreatitis, cystic fibrosis, graft-versus-host disease and Coxsackie B viral pancreatitis. The development of autoimmunity to B cells in Type 1 diabetes may be a “multistep” process in which abnormalities of major histocompatibility complex expression on islet endocrine cells are crucial events.

Key words

Pancreas islets of Langerhans antigen-immune response autoimmunity Type 1 diabetes mellitus major histocompatibility complex 


  1. 1.
    Bottazzo GF (1984) Beta-Cell damage in diabetic insulitis: are we approaching a solution? Diabetologia 26: 241–249Google Scholar
  2. 2.
    Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619–633Google Scholar
  3. 3.
    Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in Type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients unter 20 years of age in the United Kingdom. Diabetologia 29: 267–274Google Scholar
  4. 4.
    Wolf E, Spencer KM, Cudworth AG (1983) The genetic susceptibility to Type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association. Diabetologia 24: 224–230Google Scholar
  5. 5.
    Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M (1983) Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. The Lancet 2: 1115–1118Google Scholar
  6. 6.
    Alejandro R, Shienvold FL, Hajek SV, Ryan U, Miller J, Mintz DH (1982) Immunocytochemical localisation of HLA-DR in human islets of Langerhans. Diabetes 31 [Suppl 4]: 17–22Google Scholar
  7. 7.
    Natali PG, DeMartino CD, Quaranta V, Nicotra MR, Frezza F, Pellegrino MA, Ferrone S (1981) Expression of Ia-like antigens in normal human non-lymphoid tissues. Transplantation 31: 75–78Google Scholar
  8. 8.
    Gepts W, De Mey J (1978) Islet cell survival determined by morphology — an immunocytochemical study of the islets of Langerhansin juvenile diabetes mellitus. Diabetes 27 [Suppl 1]: 251–261Google Scholar
  9. 9.
    Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR (1985) In situ characterisation of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313: 353–360Google Scholar
  10. 10.
    Adams TE, Bodmer G, Bodmer WF (1983) Production and characterisation of monoclonal antibodies recognising the alpha chain subunits of human Ia alloantigens. Immunology 50: 613–624Google Scholar
  11. 11.
    Epenetos AA, Bobrow LG, Adams TE, Collins CM, Isaacson PG, Bodmer WF (1985) A monoclonal antibody that detects HLA-region antigen in routinely fixed, wax embedded sections of normal and neoplastic lymphoid tissues. J Clin Pathol 38: 12–17Google Scholar
  12. 12.
    Foulis AK, Farquharson MA (1986) Aberrant expression of HLA-DR antigens by insulin containing beta cells in recent onset Type 1 (insulin-dependent) diabetes mellitus. Diabetes 35: 1215–1224Google Scholar
  13. 13.
    Neefjes JJ, Doxiadis I, Stam NJ, Beckers CJ, Ploegh HL (1986) An analysis of Class I antigens of man and other species by one dimensional IEF and immunoblotting. Immunogenetics 23: 164–171Google Scholar
  14. 14.
    Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD (1983) Molecular biology of the cell, Garland Publishing, New York, pp 1000–1007Google Scholar
  15. 15.
    Parham P, Barnstable CJ, Bodmer WF (1979) Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C antigens. J Immunol 123: 342–349Google Scholar
  16. 16.
    Neefjes JJ, Hensen EJ, De Kroon TIP, Ploegh HL (1986) A biochemical characterisation of feline MHC products: unusually high expression of Class II antigens on peripheral blood lymphocytes. Immunogenetics 23: 341–347Google Scholar
  17. 17.
    Klareskog L, Tragardh L, Lindblom JB, Peterson PA (1978) Reactivity of a rabbit antiserum against highly purified HLA-DR antigens. Scand J Immunol 7: 199–208Google Scholar
  18. 18.
    Pujol-Borrell R, Todd I, Doshi M, Gray D, Feldmann M, Bottazzo GF (1986) Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin Exp Immunol 65: 128–139Google Scholar
  19. 19.
    Campbell IL, Bizilj K, Colman PG, Tuch BE, Harrison LC (1986) Interferon-gamma induces the expression of HLA-A,B,C but not HLA-DR on human pancreatic beta cells. J Clin Endocrin Metab 62: 1101–1109Google Scholar
  20. 20.
    Pujol-Borrell R, Todd I, Doshi M, Bottazzo GF, Sutton R, Gray D, Adolf GR, Feldmann M (1987) HLA class II induction in human islet cells by interferon-yplus tumour necrosis factor or lymphotoxin. Nature 326: 304–306Google Scholar
  21. 21.
    Lamport LA, Janossy G, Suitters AJ, Bofill M, Palmer S, Gordon-Smith E, Prentice HG, Thomas JA (1982) Immunological analysis of the skin in graft-versus-host disease. Clin Exp Immunol 50: 123–131Google Scholar
  22. 22.
    Takacs L, Szende B, Rot A, Diamanstein T (1985) Expression of MHC Class II antigens on bile duct epithelium in experimental graft-versus-host disease. Clin Exp Immunol 60: 449–456Google Scholar
  23. 23.
    Dean BM, Walker R, Bone AJ, Baird JD, Cooke A (1985) Predia, betes in the spontaneously diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC Class II molecules hi endocrine cells. Diabetologia 28: 464–466Google Scholar
  24. 24.
    Walker R, Cooke A, Bone AJ, van der Meide P, Baird JD (1986) Induction of Class II MHC antigens in vitro on pancreatic B cells isolated from BB/E rats. Diabetologia 29: 749–751Google Scholar
  25. 25.
    Sibley RK, Sutherland DER, Goetz F, Michael AF (1985) Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53: 132–144Google Scholar
  26. 26.
    Massa PT, Domes R, Meulen V (1986) Viral particles induce Ia antigen expression on astrocytes. Nature 320: 543–546Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • A. K. Foulis
    • 1
  • M. A. Farquharson
    • 1
  • R. Hardman
    • 1
  1. 1.University Department of PathologyRoyal InfirmaryGlasgowUK

Personalised recommendations